ইউরোপীয় ইউনিয়ন -
নরওয়েজীয় -
EMA (European Medicines Agency)
ravicti
immedica pharma ab - glycerolfenylbutyrat - ureasyklusforstyrrelser, innfødte - andre alimentary tract and metabolism products, - ravicti er indikert for bruk som adjunctive therapy for kronisk behandling av pasienter med urea-syklus lidelser (ucds) inkludert svekkelse av carbamoyl fosfat-syntase-jeg (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase jeg (arg) og ornithine translocase mangel hyperornithinaemia-hyperammonaemia homocitrullinuria syndrom (hhh) som ikke er administrert av kosttilskudd protein begrensning og/eller aminosyre kosttilskudd alene. ravicti må brukes med kosttilskudd protein begrensning og, i noen tilfeller, kosttilskudd (e. , essensielle aminosyrer, arginin, citrullin, proteinfri kalori kosttilskudd).
নরওয়ে -
নরওয়েজীয় -
Statens legemiddelverk
miniderm 20 %
aco hud nordic ab - glyserol - krem - 20 %
ইউরোপীয় ইউনিয়ন -
নরওয়েজীয় -
EMA (European Medicines Agency)
omvoh
eli lilly nederland b.v. - mirikizumab - kolitt, ulcerativ - immunsuppressive - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.
নরওয়ে -
নরওয়েজীয় -
Statens legemiddelverk
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med sitronsmak - 0.25 mg f
নরওয়ে -
নরওয়েজীয় -
Statens legemiddelverk
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med banansmak - 0.25 mg f
নরওয়ে -
নরওয়েজীয় -
Statens legemiddelverk
flux 0.5 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med banansmak - 0.5 mg f
নরওয়ে -
নরওয়েজীয় -
Statens legemiddelverk
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med bringebærsmak - 0.25 mg f